What is he best known for?
The fields of study he is best known for:
Mycobacterium tuberculosis, Tuberculosis, Microbiology, Virology and Gene are his primary areas of study.
His Mycobacterium tuberculosis study incorporates themes from Antibacterial agent, Mutant, Immunology, Disease and Virulence.
He works in the field of Tuberculosis, namely Isoniazid.
In his study, Complementation is strongly linked to Sigma factor, which falls under the umbrella field of Microbiology.
The concepts of his Virology study are interwoven with issues in Gene expression profiling, Central nervous system, Pattern recognition receptor and Cytosol.
His Pharmacology research is multidisciplinary, relying on both Moxifloxacin, Ethambutol and SQ109.
His most cited work include:
- The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin (193 citations)
- Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal (158 citations)
- A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. (158 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Mycobacterium tuberculosis, Tuberculosis, Microbiology, Immunology and Virology.
The Mycobacterium tuberculosis study combines topics in areas such as In vitro, Antibacterial agent, Immune system, Gene and Drug resistance.
The Gene study which covers Molecular biology that intersects with Plasmid and Regulation of gene expression.
William R. Bishai interconnects Internal medicine, Pharmacology and In vivo in the investigation of issues within Tuberculosis.
The various areas that William R. Bishai examines in his Microbiology study include Bacteria, Mutant and Virulence.
His studies deal with areas such as Tuberculin and Disease as well as Immunology.
He most often published in these fields:
- Mycobacterium tuberculosis (65.33%)
- Tuberculosis (62.67%)
- Microbiology (36.67%)
What were the highlights of his more recent work (between 2018-2021)?
- Tuberculosis (62.67%)
- Mycobacterium tuberculosis (65.33%)
- Cancer research (7.33%)
In recent papers he was focusing on the following fields of study:
William R. Bishai mostly deals with Tuberculosis, Mycobacterium tuberculosis, Cancer research, Immune system and Immunology.
His Tuberculosis research is mostly focused on the topic Mycobacterium africanum.
His Mycobacterium tuberculosis research integrates issues from Potency, Microbiology and Cytotoxicity.
Microbiology and Virulence are frequently intertwined in his study.
His studies in Cancer research integrate themes in fields like Agonist, Cytotoxic T cell, Cancer and Fusion protein.
William R. Bishai combines subjects such as Disease progression and Inhibitory postsynaptic potential with his study of Immunology.
Between 2018 and 2021, his most popular works were:
- Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2 (38 citations)
- TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis (32 citations)
- Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma (25 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Tuberculosis, Mycobacterium tuberculosis, Cancer research, Microbiology and Immunology.
His Tuberculosis study combines topics in areas such as Transmission, Drug resistance and In vivo.
William R. Bishai focuses mostly in the field of Mycobacterium tuberculosis, narrowing it down to topics relating to Immune system and, in certain cases, Antigen and RNA.
His work carried out in the field of Cancer research brings together such families of science as Suppressor, Bacterial clearance and Cancer immunotherapy.
His study on Pathogen is often connected to Phosphoproteomics as part of broader study in Microbiology.
His study in Immunology is interdisciplinary in nature, drawing from both Acquired immunodeficiency syndrome and Myeloid-derived Suppressor Cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
